Alimta

... · IN-FORUM · Subscribe Today Monday, April 18, 2005 Media Partners: Log In PressPass Past 30 Days Archive Classified Jobs Homes Apartments Cars Personals Home News Associated Press Weather Sports Opinion Valley R & R Columnists Business Farm Weddings Obituaries Photography Births Calendar Dining Special Projects Outdoors Corrections Classifieds Internet Access Marketplace Newspaperprints Travel Member Center Archive Company Site Ethics Code E-Mail Index InfoGuide Newspapers in Education Public Notices Resources Subscribe Yellow Pages Eli Lilly 1Q Profit Up Despite Weak Sales By KEN KUSMER AP Business Writer The Associated Press - Monday, April 18, 2005 · advertisement · INDIANAPOLIS, Ind.

Eli Lilly & Co.

on Monday said its profits climbed during the first quarter despite eroding sales of its anti-psychosis drug Zyprexa and attention deficit disorders treatment Strattera, which has a new warning about side effects.

Lilly also said second quarter earnings would fall short of current Wall Street estimates, but it expected to meet investors' expectations for the full year.

Lilly earned $736.6 million, or 68 cents per share, in the January-March period, up from $400.4 million, or 37 cents per share, during the same period a year ago.

The 2004 figures reflected one-time research and development costs of $362.3 million.

Excluding that expense, and assuming the expensing of stoc...

Read more...